Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Effect of Treadmill Gait Training Combined With Conventional Physiotherapy on Gait Performance and Functional Mobility in Children With Bilateral Spastic Cerebral Palsy: A Randomized Controlled Trial (GAIT-CP)

21 juli 2026 uppdaterad av: Dr. Tehreem Jameel, Syeda Khatoon e Jannat Welfare Foundation
Cerebral palsy is a neurological condition that affects movement, muscle control, and walking ability in children. Children with bilateral spastic cerebral palsy often experience increased muscle stiffness, difficulty with walking, reduced balance, and limited functional mobility. This randomized controlled trial aims to evaluate whether treadmill gait training combined with conventional physiotherapy can improve walking ability, gross motor function, balance, and mobility compared with conventional physiotherapy alone. Children with bilateral spastic cerebral palsy will receive a 12-week rehabilitation program, and changes in motor function, gait performance, spasticity, and walking endurance will be assessed before and after treatment.

Studieöversikt

Detaljerad beskrivning

Bilateral spastic cerebral palsy (CP) is associated with lower-limb spasticity, impaired motor control, abnormal gait patterns, reduced walking speed, and limitations in functional mobility. Task-specific repetitive locomotor training is an important component of pediatric neurorehabilitation, and treadmill gait training may enhance stepping practice and improve gait-related outcomes.

This assessor-blinded, parallel-group randomized controlled trial aims to evaluate the effect of treadmill gait training combined with conventional physiotherapy compared with conventional physiotherapy alone in children with bilateral spastic CP. Children aged 6-16 years with GMFCS Level I-III will be recruited from Syeda Khatoon e Jannat Trust Hospital.

Participants will be randomly allocated into two groups. The intervention group will receive treadmill gait training (30 minutes/session, 3 sessions/week for 12 weeks) in addition to conventional physiotherapy, including stretching, strengthening, balance training, and functional activities. The control group will receive conventional physiotherapy alone.

Outcomes will be assessed at baseline and after intervention using the Gross Motor Function Measure (GMFM-66) as the primary outcome, along with the 10 Meter Walk Test, Timed Up and Go Test, Pediatric Balance Scale, Modified Ashworth Scale, and 6 Minute Walk Test to evaluate gait performance, functional mobility, balance, spasticity, and walking endurance.

Studietyp

Interventionell

Inskrivning (Faktisk)

24

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Punjab Province
      • Faisalabad, Punjab Province, Pakistan, 3800
        • Syeda Khatoon e Jannat Trust Hospital & Special Education Centre

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn

Tar emot friska volontärer

Nej

Beskrivning

Inclusion Criteria

  • Clinically confirmed diagnosis of bilateral spastic cerebral palsy.
  • Aged 6 to 16 years.
  • Classified as GMFCS Levels I-III.
  • Able to stand independently, with or without support.
  • Presence of clinically significant lower-limb spasticity, defined as Modified Ashworth Scale (MAS) score ≥2.
  • Demonstrated ambulatory ability with Timed Up and Go (TUG) ≤10 seconds.
  • Demonstrated walking ability with 6-Minute Walk Test (6MWT) distance of 50-500 meters at baseline.
  • Able to understand simple verbal commands and participate in structured therapy sessions.
  • Parent or legal guardian willing to provide written informed consent.
  • Willing and able to attend the complete 12-week intervention protocol. Exclusion Criteria
  • Botulinum toxin injection within the previous 6 months.
  • Recent pharmacological intervention significantly affecting spasticity.
  • Lower-limb orthopedic surgery within the previous 12 months.
  • Severe intellectual disability (IQ <70) or inability to follow simple instructions required for therapy participation.
  • Uncontrolled seizures, epilepsy, or other neurological conditions that could interfere with participation.
  • Fixed musculoskeletal contractures limiting standing, stepping, or gait training.
  • Cardiopulmonary, medical, or orthopedic conditions that contraindicate treadmill-based exercise.
  • Current participation in another gait-training or rehabilitation research study.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Treadmill Gait Training + Conventional Physiotherapy

Participants will receive treadmill gait training combined with conventional physiotherapy for 12 weeks. Treadmill training will be provided for 30 minutes per session, 3 sessions per week (total 36 sessions). Treadmill speed, assistance level, and progression will be individually adjusted according to participant tolerance, gait quality, and safety. Sessions will be supervised by a qualified physiotherapist.

The conventional physiotherapy program will include stretching exercises, strengthening exercises, balance training, and functional task-oriented activities including sit-to-stand practice, stair training, and obstacle negotiation.

A task-specific locomotor training intervention involving treadmill walking practice for 30 minutes per session, 3 sessions per week for 12 weeks, combined with conventional physiotherapy.
A rehabilitation program including stretching, strengthening, balance training, and functional activities aimed at improving mobility and motor function in children with bilateral spastic cerebral palsy.
Aktiv komparator: Conventional Physiotherapy
Participants will receive conventional physiotherapy for 12 weeks, 3 sessions per week. The rehabilitation program will include stretching exercises, strengthening exercises, balance training, and functional task-oriented activities. The intervention will follow the same duration and frequency as the experimental group but without treadmill gait training.
A rehabilitation program including stretching, strengthening, balance training, and functional activities aimed at improving mobility and motor function in children with bilateral spastic cerebral palsy.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in Gross Motor Function Measure-66 (GMFM-66) Score
Tidsram: Baseline and Week 12
The Gross Motor Function Measure-66 (GMFM-66) is a standardized and validated observational assessment used to evaluate changes in gross motor function in children with cerebral palsy. This study will assess changes in the Standing (Dimension D) and Walking, Running, and Jumping (Dimension E) domains to evaluate improvements in functional mobility and gait-related abilities.
Baseline and Week 12

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
MAS
Tidsram: Baseline and Week 12
randomised controlled trial
Baseline and Week 12
Change in 10 Meter Walk Test (10MWT) Walking Velocity
Tidsram: Baseline and Week 12
The 10 Meter Walk Test measures walking speed over a 10-meter distance. Walking velocity (meters/second) will be assessed to determine changes in gait speed and locomotor efficiency following intervention.
Baseline and Week 12
Change in Timed Up and Go Test (TUG) Performance
Tidsram: Baseline and Week 12
The Timed Up and Go Test measures functional mobility and dynamic balance by recording the time required to stand from a chair, walk 3 meters, turn, return, and sit down.
Baseline and Week 12
Change in Pediatric Balance Scale (PBS) Score
Tidsram: Baseline and Week 12
The Pediatric Balance Scale is a 14-item performance-based measure used to assess functional balance abilities in children. Changes in balance performance will be evaluated following the intervention.
Baseline and Week 12
Change in Modified Ashworth Scale (MAS) Score
Tidsram: Baseline and Week 12
The Modified Ashworth Scale is an ordinal clinical scale used to assess changes in muscle spasticity. Lower-limb muscle groups including hip adductors, hamstrings, and gastrocnemius-soleus muscles will be evaluated.
Baseline and Week 12
Change in 6 Minute Walk Test (6MWT) Distance
Tidsram: Baseline and Week 12
The 6 Minute Walk Test measures walking endurance by recording the total distance walked in 6 minutes. It will be used to evaluate changes in functional walking capacity.
Baseline and Week 12

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
MAS
Tidsram: Baseline and Week 12
randomised controlled trial
Baseline and Week 12

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Dr. Tehreem Jameel, DPT; PGD-PPT, Syeda Khatoon e Jannat Trust Hospital & Special Education Centre

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 februari 2026

Primärt slutförande (Faktisk)

30 april 2026

Avslutad studie (Faktisk)

15 juli 2026

Studieregistreringsdatum

Först inskickad

27 juni 2026

Först inskickad som uppfyllde QC-kriterierna

27 juni 2026

Första postat (Faktisk)

6 juli 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

22 juli 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

21 juli 2026

Senast verifierad

1 juli 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

Individual participant data will not be shared with other researchers due to ethical considerations, participant confidentiality, and data protection requirements. The collected data will be used solely for the purposes specified in this study protocol. De-identified aggregated results will be reported in scientific publications and presentations to contribute to evidence-based rehabilitation practice.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera